Post-earnings recap
Reported
Tue, May 10, 2016
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Collegium Pharmaceutical reported a loss per share of $0.68, which was worse than expected. The stock reacted negatively, declining by 1.22%. Investors may be concerned about the lack of revenue information and forward guidance, which adds uncertainty to the company's outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.68 | N/A | -13.33% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.